Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy

Journal of Chemotherapy

Volumn 16, Issue SUPPL. 4, 2004, Pages 22-24

  Robert, J ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Pharmacogenetics; Phemarcogenomics

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; DRUG CARRIER; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; THIOPURINE METHYLTRANSFERASE; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG;

CANCER CHEMOTHERAPY; CANCER GENETICS; CONFERENCE PAPER; DRUG ACTIVITY; DRUG CHOICE; DRUG EFFICACY; DRUG TARGETING; DRUG TOXICITY; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; ONCOGENE; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; PRESCRIPTION; PROCESS OPTIMIZATION;

EID: 11244281056     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.supplement-1.22     Document Type: Conference Paper

References (8)

1. McLeod HL, Evans WE. Pharmacogenomics: unlocking the human genome for better drug therapy. Annu Rev Pharmacol Toxicol 2001; 41: 101-121.
2. Sekine I, Saijo N. Polymorphisms of metabolizing enzymes and transporter proteins involved in the clearance of anticancer agents. Ann Oncol 2001; 12: 1515-25.
3. Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 2003; 17: 27-41.
4. van't Veer LJ, de Jong D. The microarray way to tailored cancer treatment. Nature Med 2002; 8: 13-4.
5. Clarke PA, Poele RT, Wooster R, Workman P. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol 2001; 62: 1311-1336.
6. Friedrich MJ. Gene profiles may help predict response to chemotherapy. J Natl Cancer Inst 2002; 94: 1052-3.
7. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, Tanabe L, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000; 24: 236-244.
8. Vekris A, Meynard D, Haaz MC, Bayssas M, Bonnet J, Robert J. Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research. Cancer Res 2004; 64: 356-62.